BML Capital Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001616824

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 19 positions · Total reported value $109.22M · Top-10 concentration 93.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.1% · 3 new · 4 cut · 1 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.1% · vs SPY -0.0% · Prev Value $176.05M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -15.2% · vs SPY -17.3% · Latest Value $187.62M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, BML Capital Management, LLC disclosed 19 equity positions with a combined reported value of $109.22M. The filing implies a focused portfolio: its ten largest positions account for 93.9% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were ACRS ($27.07M), AVIR ($21.67M), ADVM ($13.85M). By sector, the heaviest allocations are Health Care 79.5%, Consumer Discretionary 1.3%. Versus the prior quarter, allocation shifted toward Health Care (+18.9pp), Consumer Discretionary (+1.3pp) and away from Industrials (-1.2pp), Other (-19.0pp).

Versus the prior quarter, BML Capital Management, LLC opened 3 new positions, trimmed 4 and fully exited 1, a turnover rate of 38.1% of positions. The portfolio's overlap with the prior quarter was 43% of names.

The largest new positions opened in Q3 2025 were IMA ($1.49M), LONA ($1.34M), TGT ($897.00K).

Of the 1 positions fully exited versus the prior quarter, the largest were THRD ($20.77M), EPIX ($7.18M), IKNA ($5.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • IMA IMAGENEBIO INC · $1.49M
  • LONA LEONABIO INC · $1.34M
  • TGT TARGET CORP · $897.00K
  • WMT WALMART INC · $518.74K
  • ARVN ARVINAS INC · $426.00K
  • MURA MURAL ONCOLOGY PUB LTD CO · $119.03K

Fully Exited (vs previous quarter)

  • THRD THIRD HARMONIC BIO INC · prev qtr: $20.77M
  • EPIX ESSA PHARMA INC · prev qtr: $7.18M
  • IKNA IKENA ONCOLOGY INC · prev qtr: $5.40M
  • MIST MILESTONE PHARMACEUTICALS IN · prev qtr: $2.20M
  • ELEV ELEVATION ONCOLOGY INC · prev qtr: $2.16M
  • TSLA TESLA INC · prev qtr: $1.65M · history
  • ATHA ATHIRA PHARMA INC · prev qtr: $975.66K
  • CRVS CORVUS PHARMACEUTICALS INC · prev qtr: $475.06K

Insider Transactions (Form 4)

Latest BML Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

BML Capital Management, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $176.05M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 18 positions · $176.05M reported value (Q2 2026)
  • Top 10 holdings = 93.3% of reported value
  • Largest position: ACRS (ACLARIS THERAPEUTICS INC) at 36.0%
  • Average position size: $9.78M

Sector Tilt

  • Health Care 80.1%
  • Consumer Discretionary 13.3%
  • Consumer Staples 6.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 4 added, 3 reduced, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 79.5%
Other 18.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 14.25M $27.07M 24.79%
24.79%
Hold
2 7.47M $21.67M 19.85%
19.85%
Reduce
3 3.06M $13.85M 12.68%
12.68%
Hold
4 645.60K $11.53M 10.56%
10.56%
Add
5 3.17M $8.36M 7.66%
7.66%
Add
6 5.29M $7.41M 6.78%
6.78%
Add
7 1.21M $4.83M 4.42%
4.42%
Hold
8 1.97M $3.07M 2.81%
2.81%
Hold
9 720.79K $2.81M 2.57%
2.57%
Add
10 1.27M $1.91M 1.75%
1.75%
Reduce
11 182.51K $1.49M 1.36%
1.36%
New
12 323.07K $1.34M 1.23%
1.23%
New
13 220.41K $1.08M 0.99%
0.99%
Hold
14 10.00K $897.00K 0.82%
0.82%
New
15 150.00K $532.50K 0.49%
0.49%
Hold
16 265 $518.74K 0.47%
0.47%
New
17 50.00K $426.00K 0.39%
0.39%
New
18 109.84K $287.78K 0.26%
0.26%
Reduce
19 57.50K $119.03K 0.11%
0.11%
New

FAQ

What did BML Capital Management, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, BML Capital Management, LLC reported 19 equity positions worth $109.22M in aggregate; its largest disclosed positions were ACRS ($27.07M), AVIR ($21.67M), ADVM ($13.85M).

How large is BML Capital Management, LLC's portfolio?

BML Capital Management, LLC reported $109.22M of long equity holdings across 19 positions as of 2025-Q3. Top-10 holdings account for 93.9% of reported value.

What is BML Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bml-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →